药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Fosfomycin
Neomycin
The risk or severity of nephrotoxicity can be increased when Neomycin is combined with Ceftriaxone.
Fosfomycin
Polymyxin B
The risk or severity of adverse effects can be increased when Ceftriaxone is combined with Polymyxin B.
Fosfomycin
Reviparin
The therapeutic efficacy of Reviparin can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Edetic acid
The therapeutic efficacy of Edetic acid can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Troxerutin
The therapeutic efficacy of Troxerutin can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Betrixaban
The therapeutic efficacy of Betrixaban can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Ticagrelor
The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Apixaban
The therapeutic efficacy of Apixaban can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Dabigatran
The therapeutic efficacy of Dabigatran can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Edetate calcium disodium anhydrous
The therapeutic efficacy of Edetate calcium disodium anhydrous can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Tocopherylquinone
The therapeutic efficacy of Tocopherylquinone can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Saruplase
The therapeutic efficacy of Saruplase can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Melagatran
The therapeutic efficacy of Melagatran can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Brinase
The therapeutic efficacy of Brinase can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Protein S human
The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Gabexate
The therapeutic efficacy of Gabexate can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Monteplase
The therapeutic efficacy of Monteplase can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Nafamostat
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Darexaban
The therapeutic efficacy of Darexaban can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Letaxaban
The therapeutic efficacy of Letaxaban can be decreased when used in combination with Ceftriaxone.